VVOS - Vivos Therapeutics announces 1-for-25 reverse stock split
2023-10-26 10:22:03 ET
More on Vivos Therapeutics
- Vivos Therapeutics, Lincare ink distribution deal
- Vivos Therapeutics GAAP EPS of -$0.18 misses by $0.04, revenue of $3.4M misses by $0.72M
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
- Historical earnings data for Vivos Therapeutics
- Financial information for Vivos Therapeutics
For further details see:
Vivos Therapeutics announces 1-for-25 reverse stock split